Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 220
Biological Threats and Terrorism: Assessing the Science and Response Capabilities - Workshop Summary
Appendix A
Biological Threats and Terrorism: How Prepared Are We? Assessing the Science and Our Response Capabilities
November 27–29, 2001
Lecture Room
National Academy of Sciences
2101 Constitution Avenue, NW
Washington, DC 20418
AGENDA
TUESDAY, NOVEMBER 27, 2001
8:30 am
Continental Breakfast
9:00
Welcome and Opening Remarks
Adel Mahmoud, Chair, Forum on Emerging Infections President, Merck Vaccines
Stanley Lemon, Vice-Chair, Forum on Emerging Infections Dean of Medicine, The University of Texas Branch at Galveston
9:15
Framing the Debate: Real-Time Considerations for Addressing Bioterrorism
Hon. William Frist, United States Senate
Anthony Fauci, National Institute of Allergy and Infectious Diseases
Edward Eitzen, U.S. Army Medical Research Institute of Infectious Diseases
James Hughes, Centers for Disease Control and Prevention
Michael Osterholm, University of Minnesota
Margaret Hamburg, Nuclear Threat Initiative
OCR for page 221
Biological Threats and Terrorism: Assessing the Science and Response Capabilities - Workshop Summary
Session I: Assessing Our Understanding of the Threats
Moderator: Joshua Lederberg, The Rockefeller University
10:15
Anthrax
Arthur Friedlander, U.S. Army Medical Research Institute of Infectious Diseases
10:45
Smallpox
Peter Jahrling, U.S. Army Medical Research Institute of Infectious Diseases
11:15
Tularemia and Plague
David Dennis, NCID, Centers for Disease Control and Prevention
11:45
Botulinum Toxin
Stephen Arnon, Infant Botulism Treatment and Prevention Program, California Department of Health Services
12:15 pm
Innovative Surveillance Methods for Monitoring Dangerous Pathogens
Patrick Kelley, Walter Reed Army Institute for Research
1:00
Lunch
Session II: Vaccines: Development, Production, Supply, and Procurement Issues
Moderator: Carole Heilman, National Institute of Allergy and Infectious Diseases
2:00
Vaccines for Threatening Agents: Ensuring the Availability of Countermeasures to Bioterrorism
Philip Russell, Office of the Secretary, Department of Health and Human Services
2:30
The Department of Defense and the Development and Procurement of Vaccines Against Dangerous Pathogens: A Role in the Military and Civilian Sector?
Anna Johnson-Winegar, Office of the Secretary of Defense, Chemical and Biological Matters
OCR for page 222
Biological Threats and Terrorism: Assessing the Science and Response Capabilities - Workshop Summary
3:00
Applications of Modern Technology to Emerging Infections and Vaccine Development
Gary Nabel, National Institute of Allergy and Infectious Diseases, Vaccine Research Center
3:30
Meeting the Regulatory and Product Development Challenges for Vaccines and Other Biologics to Address Terrorism
Jesse Goodman, Center for Biologics Evaluation and Research, Food and Drug Administration
Session III: Discussion Panel of Biological Threats and the Research Implications
4:30
Moderator: Adel Mahmoud, Merck Vaccines
Donald Burke, Johns Hopkins University
Stanley Plotkin, Aventis Pasteur
Ken Alibek, Hadron, Inc.
6:30
Adjournment of the first day
WEDNESDAY, NOVEMBER 28, 2001
8:00 am
Continental Breakfast
8:30
Opening Remarks / Summary of Day 1 Stanley Lemon, Vice Chair, Forum on Emerging Infections
Session IV: The Research Agenda and Emerging Technologies
Moderator: Gail Cassell, Eli Lilly and Company
9:30
The Role of Antivirals C.J. Peters, University of Texas-Galveston
10:00
New Research in Antitoxins John Collier, Harvard Medical School
10:30
Recombinant Human Antibody: Immediate Immunity for Botulinum Neurotoxin and Other Class A Agents
James Marks, University of California, San Francisco
11:00
Diagnostics and Detection Methods: Improving Rapid Response Capabilities
David Relman, Stanford University
OCR for page 223
Biological Threats and Terrorism: Assessing the Science and Response Capabilities - Workshop Summary
11:30
Meeting the Regulatory and Product Development Challenges for Drugs to Address Terrorism
Andrea Meyerhoff, Office of the Commissioner, Food and Drug Administration
12:30 pm
Q & A Session/Working Lunch
Session V: The Response Infrastructure
Moderator: Michael Osterholm, University of Minnesota
1:30
Lessons Being Learned: The Challenges and Opportunities
Scott Lillibridge, Office of the Secretary, Department of Health and Human Services
Julie Gerberding, Centers for Disease Control and Prevention
Bradley Perkins, Centers for Disease Control and Prevention
Kevin Yeskey, Centers for Disease Control and Prevention
3:00
The Progress, Priorities, and Concerns of Public Health Laboratories
Mary Gilchrist, University Hygienic Laboratory, Iowa
3:30
Centers for Public Health Preparedness
Stephen S. Morse, Mailman School of Public Health, Columbia University
4:00
The Role of Coordinated Information Dissemination: The CASCADE program in the United Kingdom
John Simpson, Head of Emergency Planning Co-ordination Unit, Department of Health, UK
4:30
The Legal Infrastructure for an Effective Public Health Response
David Fidler, Indiana University School of Law
Session VI: Discussion Panel of the Spectrum of Research and Public Health Responses
5:00
Moderator: James Hughes, NCID, Centers for Disease Control and Prevention
Michael Ascher, Office of the Secretary, Department of Health and Human Services
Craig Watz, Federal Bureau of Investigation
Donald Wetter, U.S. Public Health Service
David Shlaes, Wyeth-Ayerst Research
OCR for page 224
Biological Threats and Terrorism: Assessing the Science and Response Capabilities - Workshop Summary
Jerry Gibson, South Carolina Department of Health and Environmental Control
Eric Eisenstadt, Defense Advanced Research Projects Agency
Renu Gupta, Novartis
6:30
Closing Remarks /Adjournment
Stanley Lemon, Vice-Chair, Forum on Emerging Infections
THURSDAY, NOVEMBER 29, 2001
8:30 am
Continental Breakfast
9:00
Opening Remarks Adel Mahmoud, Chair Stanley Lemon, Vice-Chair
Priorities for the Next Steps in Countering Bioterrorism
9:15 am
Panel Discussion
Moderator: Fred Sparling, UNC-Chapel Hill
Panelists:
D.A. Henderson, Office of the Secretary, Department of Health and Human Services
Ruth Berkelman, Emory University
Scott Layne, UCLA
Susan Maslanka, Centers for Disease Control and Prevention
Kristi Koenig, Department of Veterans Affairs
Tom Milne, National Association of County and City Health Officials
Ronald Atlas, University of Louisville, President-Elect, American Society of Microbiology
11:15
Round-the-Table Discussion (Lunch will be served)
2:00 pm
Closing Remarks/Adjournment
Representative terms from entire chapter:
stanley lemon
